Industry

KPro can help patients maintain vision after failed keratoplasty

Healio Optometry5h ago1 min read

WASHINGTON — Patients with bilateral limbal cell deficiency or previous failed keratoplasty may be candidates for KPro, according to a speaker.In a presentation at Cornea Day at the American Society of Cataract and Refractive Surgery meeting, Soledad Cortina, MD, of the University of Illinois Eye and Ear Infirmary, said corneal transplantations have had a lot of success, and the risk associated with the first graft is generally low. However, not all patients are candidates for keratoplasty, she said, and there are situations in which she will instead turn to KPro (CorNeat).“Essentially, the

Read full article on Healio Optometry

AI Summary

Quick Take

At the ASCRS Cornea Day meeting, Dr. Soledad Cortina highlighted keratoprosthesis (KPro) as a critical alternative for patients with bilateral limbal cell deficiency or a history of failed corneal transplants. While initial keratoplasty typically enjoys high success rates, KPro devices like the CorNeat offer a viable path to vision maintenance for those who are no longer candidates for traditional human tissue grafts.

Why It Matters

Managing patients with multiple graft failures is a significant clinical hurdle, as the immunological risk increases with every subsequent procedure. For those with severe ocular surface disease or limbal stem cell deficiency, traditional donor tissue often lacks the biological support to survive, making synthetic integration a necessary shift in strategy. This discussion underscores the evolving role of synthetic corneas in treating end-stage corneal blindness where standard surgical approaches have reached their limits.

Key Details

KPro is indicated for patients with bilateral limbal cell deficiency or those who have experienced previous failed keratoplasty.
The CorNeat KPro was specifically cited as a surgical option for these complex cases.
While first-time corneal grafts generally carry low risk, subsequent grafts in certain populations have significantly lower success rates.
The presentation was delivered by Dr. Soledad Cortina of the University of Illinois Eye and Ear Infirmary during Cornea Day at ASCRS.

Practice Implications

Clinicians should consider KPro referral for patients who have exhausted traditional transplantation options or those with bilateral limbal cell deficiency where the prognosis for a standard graft is poor. Early identification of these high-risk candidates can prevent the cycle of repeated graft failures and help preserve remaining visual potential through synthetic alternatives.

Who's Affected

Cornea SpecialistsOphthalmologistsOptometristsRefractive Surgeons

Evidence StrengthModerate

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.